S Science Company, Ltd. (5721.T)
JPY 22.0
(4.76%)
JPY 22.0
(4.76%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -149.73 Million | -142.41 Million | -214.95 Million | -76.12 Million | -129.62 Million | -318.71 Million |
| Net Income | 426.42 Million | -96.6 Million | -323.33 Million | -263.8 Million | 124.94 Million | -137.77 Million |
| Depreciation & Amortization | 1.41 Million | 1.53 Million | 11.87 Million | 12.36 Million | 12.51 Million | 13.11 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 128.01 Million | -39.64 Million | 24.22 Million | 131.63 Million | 126.95 Million | -221.9 Million |
| Other non-cash items | -750.07 Million | -7.7 Million | 72.28 Million | 43.68 Million | -394.03 Million | 27.85 Million |
| Investing Cash Flow | 1.09 Billion | -289.19 Million | -76.69 Million | -43.81 Million | 641.22 Million | -50.89 Million |
| Investments in PPE | -227 Thousand | -373 Thousand | -239.5 Million | - | -370 Thousand | -15.6 Million |
| Acquisitions | - | 136.85 Million | -994 Thousand | -70.38 Million | 596 Thousand | -10 Million |
| Investment purchases | -8 Million | -433.36 Million | -21 Thousand | - | -596 Thousand | -36.15 Million |
| Sales/Maturities of investments | 542.94 Million | 4.01 Million | 169.61 Million | 500 Thousand | 643.41 Million | 12.09 Million |
| Other Investing Activities | 559.17 Million | 3.67 Million | -5.79 Million | 26.07 Million | -1.81 Million | -1.22 Million |
| Financing Cash Flow | -13 Thousand | -10 Thousand | 1.22 Billion | 2.65 Million | -63 Thousand | -266 Thousand |
| Debt repayment | - | - | - | - | - | -135 Thousand |
| Dividends payments | -13 Thousand | -10 Thousand | -11 Thousand | -93 Thousand | -51 Thousand | -124 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.22 Billion | 2.75 Million | - | - |
| Other Financing Activities | - | - | -3000.00 | -7000.00 | -12 Thousand | -7000.00 |
| Accounts receivables | 18.59 Million | 38 Million | -78 Million | 41 Million | 20.52 Million | -933 Thousand |
| Accounts payables | -44.63 Million | 39.52 Million | 20.99 Million | -88.47 Million | 1.78 Million | -4.34 Million |
| Inventory | 73.34 Million | -70.21 Million | 87.93 Million | 208.69 Million | 46.93 Million | -147.26 Million |
| Other working capital | 80.7 Million | -46.95 Million | -6.7 Million | -29.58 Million | 57.72 Million | -69.35 Million |
| Cash at beginning of period | 1.3 Billion | 1.72 Billion | 790.7 Million | 907.99 Million | 396.44 Million | 766.32 Million |
| Cash at end of period | 1.41 Billion | 1.28 Billion | 1.72 Billion | 790.7 Million | 907.99 Million | 396.44 Million |
| Capital Expenditure | -227 Thousand | -373 Thousand | -239.5 Million | - | -370 Thousand | -15.6 Million |
| Effect of forex changes on cash | - | -2000.00 | - | -1000.00 | - | -1000.00 |
| Net cash flow / Change in cash | 115.86 Million | -431.62 Million | 929.45 Million | -117.28 Million | 511.54 Million | -369.87 Million |
| Free Cash Flow | -149.96 Million | -142.78 Million | -454.45 Million | -76.12 Million | -129.99 Million | -334.32 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -77 Million | -100 Million | 426.42 Million | 147 Million | 166 Million | 213 Million |
| Depreciation & Amortization | - | - | 1.41 Million | 363 Thousand | 354 Thousand | 334 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 128.01 Million | - | - | - |
| Other non-cash items | 77 Million | 100 Million | -750.07 Million | -147 Million | -166 Million | -213 Million |
| Investing Cash Flow | - | - | 1.09 Billion | - | - | - |
| Investments in PPE | - | - | -227 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -8 Million | - | - | - |
| Sales/Maturities of investments | - | - | 542.94 Million | - | - | - |
| Other Investing Activities | - | - | 559.17 Million | - | - | - |
| Financing Cash Flow | - | - | -13 Thousand | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -13 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 18.59 Million | - | - | - |
| Accounts payables | - | - | -44.63 Million | - | - | - |
| Inventory | - | - | 73.34 Million | - | - | - |
| Other working capital | - | - | 80.7 Million | - | - | - |
| Cash at beginning of period | - | - | 1.3 Billion | 1.3 Billion | 1.06 Billion | 1.3 Billion |
| Cash at end of period | - | - | 1.41 Billion | 1.9 Billion | 1.3 Billion | 1.06 Billion |
| Capital Expenditure | - | - | -227 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 115.86 Million | 599.54 Million | 239.26 Million | -238.41 Million |
| Free Cash Flow | - | - | -149.96 Million | 726 Thousand | 708 Thousand | 668 Thousand |
CMNT
LSEG
ADVT
038540
UNJHAFOR
MTEM